Enzo Biochem, Inc. (NYSE:ENZ) Consolidated Diluted EPS Stands At $-0.0504

0

For the period ended 2015-07-31, Enzo Biochem, Inc. (NYSE:ENZ) delivered annual basic consolidated EPS of $-0.0504. In terms of quarterly performance, the basic consolidated EPS was $-0.0504 for the quarter ended 2015-07-31.

What about EPS from continuing operations?

Enzo Biochem, Inc. (NYSE:ENZ) produced $-0.0504 in basic EPS from continuing operations for the annual period ended 2015-07-31. For the quarter, basic EPS from continuing operations was $-0.0504 for the three-month period ended 2015-07-31.

how much did parent contribute in EPS?

Enzo Biochem, Inc. (NYSE:ENZ) received basic EPS boost of $-0.0504 from its parent company for the annual period ended 2015-07-31. For quarterly metrics, basic EPS contribution from the parent company was $-0.0504 for the three-month period ended 2015-07-31.

Basic net EPS

Enzo Biochem, Inc. (NYSE:ENZ) posted basic net EPS of $-0.05 for the annual period ended 2015-07-31. On quarterly basis, the basic net EPS for the quarter ended 2015-07-31 was $-0.05.

Consolidated diluted EPS

Enzo Biochem, Inc. (NYSE:ENZ) produced annual consolidated diluted EPS of $-0.0504 for the period ended 2015-07-31. But consolidated diluted EPS stood at $-0.0504 for the quarter ended 2015-07-31.

Basic diluted EPS

Basic diluted EPS of $-0.0504 came from continuing operation for the annual period ended 2015-07-31. In terms of quarterly performance, diluted EPS from continuing operations was $-0.0504 for the quarter ended 2015-07-31.

Net diluted EPS

The company posted net diluted EPS of $-0.05 for the annual period ended 2015-07-31. Coming to the quarter, it posted net diluted EPS of $-0.05 for the three-month period ended 2015-07-31.

Diluted EPS from parent

Enzo Biochem, Inc. (NYSE:ENZ) received diluted EPS boost of $-0.0504 from the parent company for the annual period ended 2015-07-31. For the quarter, diluted EPS from the parent was $-0.0504 for the quarter ended 2015-07-31.

For the annual period ended 2015-07-31, Enzo Biochem, Inc. (NYSE:ENZ) produced net basic EPS of $-0.05. On quarterly basis, it posted basic net EPS of $-0.05, which was for the three-month period ended 2015-07-31.

The annual average of the company’s basic shares outstanding was 45.355 for the period ended 2015-07-31. The quarterly average of basic shares outstanding was 45.355 for the quarter ended 2015-07-31.

The company had diluted shares outstanding of 45.608 for the annual period ended 2015-07-31 and 45.608 for the quarterly period ended 2015-07-31.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 10 times, 1 visits today)